High street pharmacies throughout England have begun administering free meningitis B vaccines as part of a targeted campaign launched following a substantial disease outbreak. The initiative makes vaccines available to approximately one million young people, with eligibility criteria including 17 and 18-year-olds in sixth form and students under 25 entering residential university or college settings for the first time this autumn.
Booking appointments commenced on Monday 13 July, with initial appointments available starting Monday 20 July. Eligible individuals can register through the NHS National Booking Service if registered with a general practitioner, or access walk-in services at participating pharmacies without prior registration. The vaccine requires two doses administered at least 28 days apart to provide optimal protection.
The vaccination campaign responds to a meningitis B outbreak that occurred in Kent earlier this year, characterized as unprecedented and explosive in nature. Within weeks, the outbreak produced 29 confirmed or suspected cases and two deaths in the Kent region. Health officials note that students in their first year of university face approximately seven times higher infection risk compared to non-university young people of similar age, attributed to increased social mixing and shared accommodation arrangements.
Meningitis B infection can result in severe complications including meningitis, sepsis, and potentially life-changing disabilities such as hearing loss, amputation, or brain damage. The vaccine does not contain live bacteria and cannot cause meningitis. Common side effects include injection site reactions and mild symptoms such as fever or headache that typically resolve within one to two days, with serious adverse effects remaining rare.
While the MenB vaccine was incorporated into routine childhood immunizations for babies born after 1 July 2015, teenagers and older young adults previously missed this protection. Vaccine experts have suggested government consideration of routine teenage vaccination around age 15, though individual nations retain decision-making authority on implementation.